Vertex Pharmaceuticals reported positive results Tuesday for two Phase 3 trials testing the efficacy and safety of pain compound VX-548 compared to either placebo or opioid-based treatment. While both ...

A Pharvaris drug led to speedy relief and symptom resolution from the sudden swelling attacks caused by a rare genetic disorder, preliminary Phase 3 clinical trial results that pave the way for an FDA ...

Viking TherapeuticsVKTX stock remains under pressure, but analysts said Wednesday the company's strategy for its Phase 3 obesity studies could pay off big time against bigger rival Eli LillyLLY. The ...

Novartis’s $3.2 billion acquisition of Chinook Therapeutics brought two drug prospects for a chronic kidney disorder with few approved treatments. One of these newly acquired drugs has now met the ...